BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

Nature Immunology

Volumn 4, Issue 7, 2003, Pages 670-679

  Watanabe, Norihiko ^a,d   Gavrieli, Maya ^a   Sedy, John R ^a   Yang, Jianfei ^a,e   Fallarino, Francesca ^b   Loftin, Susan K ^a   Hurchla, Michelle A ^a   Zimmerman, Natalie ^a   Sim, Julia ^a   Zang, Xingxing ^c   Murphy, Theresa L ^a   Russell, John H ^a   Allison, James P ^c   Murphy, Kenneth M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PERUGIA   (Italy)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOPROTEIN; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; PROTEIN BTLA; PROTEIN PD 1; PROTEIN TYROSINE PHOSPHATASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE SEQUENCE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; SRC HOMOLOGY DOMAIN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOCONJUGATES; INTERLEUKIN-2; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; PROTEINS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SHP1 PROTEIN TYROSINE PHOSPHATASE; T-LYMPHOCYTES;

EID: 0037810670     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni944     Document Type: Article

References (51)

1. Coyle, A.J. & Gutierrez-Ramos, J.C. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2, 203-209 (2001).
2. Hutloff, A. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263-266 (1999).
3. Swallow, M.M., Wallin, J.J. & Sha, W.C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFα. Immunity 11, 423-432 (1999).
4. Yoshinaga, S.K. et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402, 827-832 (1999).
5. Ling, V. et al. Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 164, 1653-1657 (2000).
6. Wang, S. et al. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96, 2808-2813 (2000).
7. Brodie, D. et al. LICOS, a primordial costimulatory ligand? Curr. Biol. 10, 333-336 (2000).
8. Liang, L. & Sha, W.C. The right place at the right time: novel B7 family members regulate effector T cell responses. Curr. Opin. Immunol. 14, 384-390 (2002).
9. Liang, L., Porter, E.M. & Sha, W.C. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. J. Exp. Med. 196, 97-108 (2002).
10. Ishida, Y. et al. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887-3895 (1992).
11. Nishimura, H. et al. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10, 1563-1572 (1998).
12. Freeman, G.J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034 (2000).
13. Dong, H. et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5, 1365-1369 (1999).
14. Latchman, Y. et al. PD-L2 is a second ligand for PD-I and inhibits T cell activation. Nat. Immunol. 2, 261-268 (2001).
15. Tseng, S.Y. et al. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193, 839-846 (2001).
16. Chapoval, A.I. et al. B7-H3: a costimulatory molecule for T cell activation and IFN-γ production. Nat. Immunol. 2, 269-274 (2001).
17. Sun, M. et al. Characterization of mouse and human B7-H3 genes. J. Immunol. 168, 6294-6297 (2002).
18. Yang, J. et al. IL-18-stimulated GADD45β required in cytokine-induced, but not TCR-induced, IFN-γ production. Nat. Immunol. 2, 157-164 (2001).
19. Tomasello, E. et al. Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells. Semin. Immunol. 12, 139-147 (2000).
20. Bolland, S. & Ravetch, J.V. Inhibitory pathways triggered by ITIM-containing receptors. Adv. Immunol. 72, 149-177 (1999).
21. Shiratori, T. et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 6, 583-589 (1997).
22. Zhang, Y. & Allison, J.P. Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein. Proc. Natl. Acad. Sci. USA 94, 9273-9278 (1997).
23. Songyang, Z. et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14, 2777-2785 (1994).
24. Nishimura, H. et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151 (1999).
25. Shlapatska, L.M. et al. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol. 166, 5480-5487 (2001).
26. Haskins, K. et al. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J. Exp. Med. 157, 1149-1169 (1983).
27. Okazaki, T. et al. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting Src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA 98, 13866-13871 (2001).
28. + T cells. Eur. J. Immunol. 28, 3137-3143 (1998).
29. Oosterwegel, M.A. et al. The role of CTLA-4 in regulating Th2 differentiation. J. Immunol. 163, 2634-2639 (1999).
30. Greenwald, R.J. et al. CTLA-4 regulates induction of anergy in vivo. Immunity 14, 145-155 (2001).
31. Sabelko-Downes, K.A., Cross, A.H. & Russell, J.H. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J. Exp. Med. 189, 1195-1205 (1999).
32. Sharpe, A.H. & Freeman, G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2, 116-126 (2002).
33. Tivol, E.A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multi-organ tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3, 541-547 (1995).
34. + T regulatory cells. Nat. Immunl. 4, 337-342 (2003).
35. Bachmann, M.F. et al. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128-1131 (1999).
36. Bachmann, M.F. et al. Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur. J. Immunol. 31, 450-458 (2001).
37. Tivol, E.A. & Gorski, J. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4. J. Immunol. 169, 1852-1858 (2002).
38. Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3, 1097-1101 (2002).
39. Finger, E.B. & Bluestone, J.A. When ligand becomes receptor - tolerance via B7 signaling on DCs. Nat. Immunol. 3, 1056-1057 (2002).
40. Nishimura, H. et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291, 319-322 (2001).
41. Bennett, F. et al. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 170, 711-718 (2003).
42. + T cells and is overcome by IL-2. Eur. J. Immunol. 32, 634-643 (2002).
43. Brunner, M.C. et al. CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162, 5813-5820 (1999).
44. Luhder, F. et al. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187, 427-432 (1998).
45. Luhder, F. et al. Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells. Proc. Natl. Acad. Sci. USA 97, 12204-12209 (2000).
46. Abiru, N., Kawasaki, E. & Eguch, K. Current knowledge of Japanese type 1 diabetic syndrome. Diabetes Metab. Res. Rev. 18, 357-366 (2002).
47. Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature; advance online publication 30 April 2003/ doi 10.1038/nature01621.
48. Ranganath, S. et al. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161, 3822-3826 (1998).
49. + T cells. Nat. Immunol. 3, 549-557 (2002).
50. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549 (1993).
51. Sha, W.C. et al. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335, 271-274 (1988).